Abstract: A novel B.t. gene encoding a toxin which is toxic to coleopteran insects has been cloned from a coleopteran-active B. thurningiensis microbe. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control coleopteran insects in various environments.
Type:
Grant
Filed:
June 12, 1991
Date of Patent:
February 16, 1993
Assignee:
Mycogen Corporation
Inventors:
Kenneth E. Narva, George E. Schwab, Gregory A. Bradfisch
Abstract: Certain isolates of Bacillus thuringiensis (B.t.) have been found to have activity against Scarab pests. These isolates are designated B.t. PS86B1, B.t. PS43F and B.t. PS50C. These isolates, or transformed hosts containing the gene expressing a Scarab-active toxin obtained from the isolates, can be used to control Scarab-active pests, e.g., Masked Chafer, Cyclocephala sp., June Beetle, Cotinis sp., Northern Masked Chafer, Cyclocephala borealis, Japanese Beetle, Popillia japonica, and Pasedena Masked Chafer, Cyclocephala pasadenae, in various environments.
Abstract: A novel B.t. isolate with activity against lepidopteran insects is disclosed. This isolate is highly active agaist the beet armyworm. A gene from this isolate has been cloned. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control lepidopteran insects in various environments.
Type:
Grant
Filed:
November 1, 1988
Date of Patent:
December 8, 1992
Assignee:
Mycogen Corporation
Inventors:
Jewel Payne, August J. Sick, Mark Thompson
Abstract: The invention is a process for controlling the expression of heterologous genes from lac-operated promoters by removing the CAP binding site and lac promoter from the lac operon. Illustrated is the fusion of the lacZ, Y, and A genes of the lac operon to the 3' end of the lacI structural gene. This elimination of the natural regulatory elements of the lac operon results, advantageously, in the production of lac operon gene products in a constitutive mode from the lacI promoter.
Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used to transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
Abstract: The invention concerns novel isolates of Bacillus thuringiensis (B.t.) which contain a toxin(s) which is active against nematodes. This B.t. toxin(s) or B.t. isolate(s) can be used to treat animals and plants hosting susceptible nematodes.
Abstract: A novel B.t. isolate with activity against lepidopteran insects is disclosed. This isolate is highly active against the beet armyworm. A gene from this isolate has been cloned. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control lepidopteran insects in various environments.
Type:
Grant
Filed:
November 16, 1990
Date of Patent:
August 4, 1992
Assignee:
Mycogen Corporation
Inventors:
Jewel Payne, August J. Sick, Mark Thompson
Abstract: A novel B.t. toxin gene encoding a protein toxic to coleopteran insects has been cloned from a novel coleopteran-active B. thuringiensis microbe. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control coleopteran insects in various environments.
Abstract: A novel hybrid B.t. toxin gene toxic to lepidopteran insects has been cloned. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control lepidopteran insects in various environments.
Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used to transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
Abstract: The subject invention concerns the use of a novel and useful bioinsecticide against the lesser mealworm (Alphitobius diaperinus). The lesser mealworm is a devastating pest in the poultry industry. The bioinsecticide of the subject invention is a novel B. thuringiensis microbe referred to as B.t. PS122D3, or mutants thereof. The spores or toxin crystals of this microbe are useful to control the lesser mealworm in various environments.
Type:
Grant
Filed:
September 11, 1990
Date of Patent:
April 21, 1992
Assignee:
Mycogen Corporation
Inventors:
Leslie A. Hickle, Gregory A. Bradfisch, Jewel M. Payne
Abstract: A novel B.t. toxin gene encoding a protein toxic to coleopteran insects has been cloned from a novel coleopteran-active B. thuringiensis microbe. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control coleopteran insects in various environments.
Abstract: The subject invention concerns the use of a novel and useful bioinsecticide against the lesser mealworm (Alphitobius diaperinus). The lesser mealworm is a devastating pest in the poultry industry. The bioinsecticide of the subject invention is a novel B. thuringiensis microbe referred to as B.t. PS86B1, or mutants thereof. The spores or toxin crystals of this microbe are useful to control the lesser mealworm in various environments.
Type:
Grant
Filed:
September 11, 1990
Date of Patent:
March 31, 1992
Assignee:
Mycogen Corporation
Inventors:
Leslie A. Hickle, Gregory A. Bradfisch, Jewel M. Payne
Abstract: The subject invention concerns the use of a novel and useful bioinsecticide against the lesser mealworm (Alphitobius diaperinus). The lesser mealworm is a devastating pest in the poultry industry. The bioinsecticide of the subject invention is a novel B. thuringiensis microbe referred to as B.t. PS40D1, or mutants thereof. The spores or toxin crystals of this microbe are useful to control the lesser mealworm in various environments.
Type:
Grant
Filed:
September 11, 1990
Date of Patent:
March 24, 1992
Assignee:
Mycogen Corporation
Inventors:
Leslie A. Hickle, Gregory A. Bradfisch, Jewel M. Payne
Abstract: The subject invention concerns the use of a novel and useful bioinsecticide against the lesser mealworm (Alphitobius diaperinus). The lesser mealworm is a devastating pest in the poultry industry. The bioinsecticide of the subject invention is a novel B. thuringiensis microbe referred to as B.t. MT 104, or mutants thereof. The spores or toxin crystals of this microbe are useful to control the lesser mealworm in various environments.
Type:
Grant
Filed:
September 11, 1990
Date of Patent:
March 3, 1992
Assignee:
Mycogen Corporation
Inventors:
Leslie A. Hickle, Gregory A. Bradfisch, Jewel M. Payne
Abstract: The invention concerns novel isolates of Bacillus thuringiensis (B.t.) which contains a toxin(s) which is active against adult nematode worms and larvae. This B.t. toxin(s) can be used to treat animals and plants hosting susceptible nematodes.
Type:
Grant
Filed:
May 24, 1990
Date of Patent:
March 3, 1992
Assignee:
Mycogen Corporation
Inventors:
David L. Edwards, Jewel Payne, George G. Soares
Abstract: The subject invention concerns the use of a novel and useful bioinsecticide against the lesser mealworm (Alphitobius diaperinus). The lesser mealworm is a devasting pest in the poultry industry. The bioinsecticide of the subject invention is a novel B. thuringiensis microbe referred to a B.t. PS43F, or mutants thereof. The spores or toxin crystals of this microbe are useful to control the lesser mealworm in various environments.
Type:
Grant
Filed:
September 11, 1990
Date of Patent:
November 12, 1991
Assignee:
Mycogen Corporation
Inventors:
Leslie A. Hickle, Gregory A. Bradfisch, August J. Sick
Abstract: A novel hybrid B.t. toxin gene toxic to lepidopteran insects has been cloned. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control lepidopteran insects in various environments.
Abstract: A novel B.t. toxin gene toxic to lepidopteran insects has been cloned from a novel lepidopteran-active B. thuringiensis microbe. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control lepidopteran insects in various environments.
Abstract: A novel B.t. toxin gene encoding a protein toxic to lepidopteran insects has been cloned from a novel lepidopteran-active B. thuringiensis microbe. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control lepidopteran insects in various environments.